Lymphoma News
May 26, 2015

Latest Headlines
updated 11:55pm EDT

More Lymphoma News
May 26, 2015

Changes in Cancer Epigenome Implicated in Chemotherapy Resistance, Lymphoma Relapse

Apr. 20, 2015 — Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings indicate ... read more

Apr. 14, 2015 — The first-ever systematic study of the genomes of patients with ALK-negative anaplastic large cell lymphoma, a particularly aggressive form of non-Hodgkin's lymphoma, has been concluded. The ... read more

New Assay Helps Determine Lymphoma Subtypes Simply, Quickly, and Inexpensively

Apr. 16, 2015 — With the advent of targeted lymphoma therapies on the horizon, it becomes increasingly important to differentiate the two major subtypes of diffuse large B-cell lymphoma (DLBCL), which is the most ... read more

Promising Developments in Tackling Resistance to Blood Cancer Drugs

Apr. 13, 2015 — A drug with the potential to reverse resistance to immunotherapy has been developed by scientists, showing great promise in pre-clinical models. Researchers say that it will be available to patients ... read more

Central Signaling Pathway in Lymphoma Can Be Blocked Successfully

Apr. 7, 2015 — Cancer researchers have identified a key signaling pathway in B-cell lymphoma, a malignant type of blood cancer. They demonstrate that the signaling pathway can be blocked using compounds that are ... read more

Low Vitamin D Linked to Worse Prognosis in Type of Non-Hodgkin Lymphoma

Mar. 30, 2015 — People with lower vitamin D levels prior to treatment for follicular lymphoma succumb to the disease or face relapse earlier than patients with sufficient vitamin D levels in their blood, a new study ... read more

Experts Set Strategic Priorities for Lymphoma Research

Mar. 26, 2015 — A committee of lymphoma experts has unveiled a strategic roadmap identifying key priority areas in both infrastructure and research that will be critical for advancing treatments for people with ... read more

Spherical Nucleic Acids Set Stage for New Paradigm in Drug Development

Mar. 16, 2015 — Spherical nucleic acids (SNAs) can be used as potent drugs to effectively train the immune system to fight disease, by either boosting or dampening the immune response. By increasing the immune ... read more

Targeted Drug Doubles Progression Free Survival in Hodgkin Lymphoma

Mar. 19, 2015 — A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell ... read more

Genetically Engineered Immunotoxin Shows Early Promise in Patients With B-Cell Malignancies

Mar. 13, 2015 — DT2219, a new bispecific ligand-directed diphtheria toxin, was found to be safe and clinically effective in a small group of patients with relapsed/refractory B-cell malignancies, according to phase ... read more

Mar. 12, 2015 — A new genome editing technology has been developed that can target and kill blood cancer cells with high accuracy. Using the technology, researchers were able to kill human lymphoma cells by locating ... read more

Childhood Leukemia Study Reveals Disease Subtypes, New Treatment Option

Mar. 9, 2015 — A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence ... read more

Treatment Guidelines for Pediatric Hodgkin Lymphoma Outlined

Mar. 4, 2015 — A guideline has been issued that outlines the use of 3-D computed tomography (CT)-based radiation therapy planning and volumetric image guidance to more effectively treat pediatric Hodgkin lymphoma ... read more

Jan. 26, 2015 — Scientists have revealed how a type of cancer-causing virus outwits the human body's immune response. The discovery might help explain why some cancer therapies that incorporate interferon fail ... read more

Jan. 12, 2015 — Targeting a cell 'survival' protein could help treat some lymphomas, including those cancers with genetic defects that make them resistant to many existing therapies, researchers have ... read more

Added Benefit of Idelalisib Is Not Proven

Jan. 8, 2015 — The drug manufacturer presented no suitable data to evaluators for the therapeutic indication chronic lymphocytic leukaemia or for refractory follicular ... read more

Dec. 18, 2014 — Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor ... read more

Effectiveness of Drugs to Prevent Hepatitis Among Patients Receiving Chemotherapy

Dec. 16, 2014 — Among patients with lymphoma undergoing a certain type of chemotherapy, receiving the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV ... read more

Cancer Therapy Using Specialized Apheresis Holds Great Promise

Dec. 11, 2014 — Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists. In the case of ECP, investigators' ... read more

Immunotherapy Shows Clinical Benefit in Relapsed Transplant Recipients

Dec. 9, 2014 — A multicenter phase 1 trial of the immune checkpoint blocker ipilimumab found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation, ... read more

Monday, April 20, 2015
Tuesday, April 14, 2015
Thursday, April 16, 2015
Monday, April 13, 2015
Tuesday, April 7, 2015
Monday, March 30, 2015
Thursday, March 26, 2015
Monday, March 16, 2015
Thursday, March 19, 2015
Friday, March 13, 2015
Thursday, March 12, 2015
Monday, March 9, 2015
Wednesday, March 4, 2015
Monday, January 26, 2015
Monday, January 12, 2015
Thursday, January 8, 2015
Thursday, December 18, 2014
Tuesday, December 16, 2014
Thursday, December 11, 2014
Tuesday, December 9, 2014
Sunday, December 7, 2014
Wednesday, November 19, 2014
Monday, November 17, 2014
Wednesday, November 5, 2014
Wednesday, October 22, 2014
Sunday, October 19, 2014
Monday, October 6, 2014
Wednesday, September 17, 2014
Tuesday, September 9, 2014
Monday, August 25, 2014
Friday, August 22, 2014
Tuesday, August 19, 2014
Monday, August 4, 2014
Sunday, July 27, 2014
Monday, July 14, 2014
Monday, July 7, 2014
Monday, June 30, 2014
Thursday, June 26, 2014
Thursday, June 19, 2014
Monday, June 9, 2014
Friday, May 30, 2014
Wednesday, May 28, 2014
Sunday, May 25, 2014
Friday, May 23, 2014
Thursday, May 8, 2014
Tuesday, April 29, 2014
Thursday, April 10, 2014
Tuesday, April 8, 2014
Monday, April 7, 2014
Wednesday, March 19, 2014
Thursday, March 20, 2014
Wednesday, March 19, 2014
Monday, March 10, 2014
Tuesday, February 25, 2014
Monday, February 17, 2014
Thursday, February 13, 2014
Friday, January 31, 2014
Thursday, January 23, 2014
Tuesday, January 14, 2014
Tuesday, January 7, 2014
Thursday, December 19, 2013
Wednesday, December 18, 2013
Wednesday, December 11, 2013
Tuesday, December 10, 2013
Friday, November 22, 2013
Wednesday, November 13, 2013
Wednesday, October 30, 2013
Monday, October 14, 2013
Saturday, October 12, 2013
Wednesday, October 2, 2013
Wednesday, August 21, 2013
Tuesday, August 27, 2013
Friday, August 16, 2013
Thursday, August 8, 2013
Monday, August 5, 2013
Thursday, August 1, 2013
Sunday, July 28, 2013
Monday, July 29, 2013
Tuesday, July 16, 2013
Tuesday, June 25, 2013
Wednesday, June 19, 2013
Thursday, May 30, 2013
Tuesday, May 21, 2013
Monday, May 13, 2013
Tuesday, April 16, 2013
Sunday, April 7, 2013
Tuesday, April 2, 2013
Monday, April 1, 2013
Wednesday, March 13, 2013
Sunday, March 3, 2013